Meredith C. Keller

Meredith Keller practices at Surgical Specialty Care in Albuquerque, New Mexico.

Meredith Keller's NPI, 1780145300, was assigned on March 27, 2019. Meredith Keller holds New Mexico license DO2024-0039.

Meredith Keller's primary practice is Surgical Specialty Care, at 4901 Lang Ave Ne, Albuquerque, NM 87109. The practice phone is (505) 842-8171.

Meredith Keller's primary practice is Surgical Specialty Care in Albuquerque, New Mexico. The medical group on file is New Mexico Cancer Center (NMCC). Dmand AI also links Meredith Keller to 1 more group practice or clinic and 1 therapy and rehab clinic, each named with a free account. Meredith Keller's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Meredith Keller practices, 3 sites in all. Vendor and product names are available with a free account.

Rheumatology is Meredith Keller's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Meredith Keller is licensed in New Mexico.

CMS data shows 363 Medicare services from Meredith Keller across 7 procedure codes in 2024, for 106 Medicare patients. Medicare paid $17,822 for them. Every service was in an office.

CMS counts 106 Medicare patients who saw Meredith Keller in 2024. The largest group is 65 to 74, with 48 patients. 75% of them have arthritis, and 67% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Meredith Keller's median patient age at 62, with 78% women.

In 2024, Meredith Keller wrote 899 Medicare Part D claims for 198 patients. 77% of them were for generic drugs. CMS names the drug for 696 of them, across 25 drugs with 11 or more claims each, at $757,848 in total drug cost. In 2023, CMS named 347 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Meredith Keller for performance year 2024, reported as part of a group. Meredith Keller accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Meredith Keller as offering telehealth.

Dmand AI links 2 papers to Meredith Keller, published from 2023 to 2024. Meredith Keller's most frequent co-authors are Maheswari Muruganandam, MBBS, Wilmer L. Sibbitt, MD and Roderick A. Fields, MD.

CMS Open Payments shows 67 general payments to Meredith Keller from 12 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $506.